Molina Healthcare Inc.

NYSE: MOH · Real-Time Price · USD
167.28
7.65 (4.79%)
At close: Aug 15, 2025, 3:11 PM

Molina Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
43.41B 41.84B 40.63B 39.18B 37.39B 35.85B 34.07B 33.25B 32.63B 32.35B 31.97B 31.16B 30.27B 29.02B 27.77B 25.6B 23.58B 21.4B
Cost of Revenue
38.27B 37.07B 35.91B 34.53B 32.87B 31.41B 29.74B 28.95B 28.44B 28.32B 28.05B 27.4B 26.68B 25.6B 24.49B 22.57B 20.65B 18.47B
Gross Profit
2.3B 4.78B 4.71B 4.64B 4.52B 4.45B 4.33B 4.3B 4.19B 4.03B 3.93B 3.76B 3.59B 3.42B 3.28B 3.03B 2.93B 2.92B
Operating Income
1.65B 1.71B 1.71B 1.64B 1.53B 1.54B 1.57B 1.57B 1.55B 1.46B 1.38B 1.26B 1.15B 1.06B 1.02B 920M 988M 1.14B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
1.5B 1.58B 1.59B 1.53B 1.43B 1.44B 1.46B 1.25B 1.23B 1.15B 1.06B 1.12B 1B 914M 875M 790M 861M 1.01B
Net Income
1.13B 1.18B 1.18B 1.14B 1.06B 1.07B 1.09B 931M 916M 855M 792M 839M 752M 689M 659M 590M 632M 723M
Selling & General & Admin
2.83B 2.81B 2.74B 2.72B 2.65B 2.58B 2.46B 2.45B 2.4B 2.33B 2.31B 2.26B 2.23B 2.17B 2.07B 1.94B 1.77B 1.64B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
187M -891M -2.06B -3.4B 4.13B 12.48B 13.63B 14.97B 7.45B 238M 234M 147M 120M 104M 101M 116M 108M 64M
Operating Expenses
3.01B 3.38B 3.62B 3.62B 11.08B 10.68B 10.24B 10.21B 2.64B 2.57B 2.54B 2.5B 2.44B 2.36B 2.26B 2.11B 1.94B 1.78B
Interest Expense
154M 134M 118M 111M 109M 108M 109M 109M 110M 110M 110M 113M 115M 118M 120M 120M 117M 111M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
41.28B 21.26B 1.04B -346M -2.03B 15.3B 32.5B 31.68B 31.08B 30.89B 30.59B 29.9B 29.13B 27.96B 26.75B 24.68B 22.59B 20.26B
Income Tax Expense
369M 404M 410M 388M 363M 365M 373M 322M 312M 291M 271M 282M 253M 225M 216M 200M 229M 290M
Shares Outstanding (Basic)
54.3M 54.6M 57.4M 57.6M 57.9M 57.9M 58M 57.8M 57.7M 58M 58M 57.6M 57.8M 58M 58M 57.8M 57.7M 57.7M
Shares Outstanding (Diluted)
54.3M 54.8M 57.7M 57.7M 58.2M 58.3M 58.2M 58.1M 57.9M 58M 58.4M 57.6M 58.4M 58.7M 58.7M 58.5M 58.4M 58.6M
EPS (Basic)
20.22 20.70 20.43 19.78 18.36 18.52 18.85 16.10 15.85 14.78 13.70 14.51 13.01 11.92 11.42 10.21 10.86 12.38
EPS (Diluted)
20.19 20.62 20.33 19.69 18.26 18.43 18.80 16.05 15.82 14.73 13.60 14.38 12.85 11.76 11.25 10.07 10.71 12.20
EBITDA
1.85B 1.9B 1.89B 1.82B 1.71B 1.72B 1.74B 1.54B 1.52B 1.44B 1.35B 1.4B 1.27B 1.17B 1.13B 1.03B 1.09B 1.23B
EBIT
1.65B 1.71B 1.71B 1.64B 1.53B 1.54B 1.57B 1.36B 1.34B 1.26B 1.17B 1.23B 1.12B 1.03B 995M 910M 978M 1.12B
Depreciation & Amortization
201M 189M 186M 181M 176M 172M 171M 175M 178M 180M 176M 164M 151M 138M 131M 120M 111M 101M